UC Davis Health Thursday began a planned clinical trial for a potential COVID-19 vaccine that will involve approximately 30,000 participants around the world. Locally, six people received the vaccine injection. The UC Davis Health trial is expected to enroll about 200 participants.
"I'm excited about being able to be afforded the opportunity to help the world tackle this pandemic," said Lucas Solano, 27, who enrolled in the trial a few days ago and received the injection Thursday. "It's exciting to be one of the people that essentially would take the initiative and be helpful, if this vaccine became approved and distributed worldwide."
The trial, which headed by pharmaceutical giant Pfizer and BioNTech, is still accepting participants. If you'd like to participate, click here for more details.
The vaccine candidate has already undergone preliminary evaluations in the United States and Germany and has previously shown significant positive results, according to Pfizer officials.
UC Davis Health is one of only 120 sites taking part in the trial.